Fungicidal compositions

Abstract

A fungicidal composition comprising a mixture of components (A) and (B), wherein components (A) and (B) are as defined in claim 1, and the use of said composition for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi, in agriculture or horticulture.

Description

[0001] This invention relates to novel antifungal compositions, their use in agriculture or horticulture for controlling diseases caused by plant pathogens (especially plant pathogenic fungi), and methods for controlling diseases on beneficial plants.

[0002] WO 2010 / 012793, WO 2017 / 207362 and WO 2019 / 105933 describe thiazole derivatives as pest control agents.

[0003] Although many fungicidal compounds and compositions belonging to various chemical classes have been developed or are being developed for use as fungicides in beneficial plant crops, crop tolerance and activity against specific plant pathogens do not always meet the needs of agricultural practice in many respects. Therefore, there is a persistent need to discover new compounds and compositions with superior biological properties for the control or prevention of plant infection by plant pathogens. For example, compounds with greater biological activity, favorable activity spectra, increased safety, improved physicochemical properties, or increased biodegradability; or, alternatively, compositions with broader activity spectra, improved crop tolerance, improved synergistic interactions or enhancing properties, or compositions exhibiting faster onset of action or longer residual activity, or compositions that reduce the number of applications and / or application rate required for effective control of plant pathogens, thereby enabling beneficial tolerance management practices, reducing environmental impact, and reducing operator exposure.

[0004] Some of these needs can be addressed by using compositions containing mixtures of different fungicidal compounds with different modes of action (e.g., by combining fungicides with different activity spectra).

[0005] According to the present invention, an antifungal composition is provided, the composition comprising a mixture of components (A) and (B) as an active ingredient, wherein component (A) is a compound having formula (I):

[0006]

[0007] in

[0008] Y is either CF or CH;

[0009] X is N;

[0010] R 1 It is a C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or HC(O)NH-;

[0011] R 2It is a C1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl, C1-C2 alkyl (wherein the cycloalkyl is optionally composed of 1 to 3 R 3 (represented by a substituent group), phenyl, phenyl C1-C2 alkyl (wherein the phenyl ring is optionally replaced by 1 to 3 R groups). 3 (represented by group substitution), or a 5- to 12-membered non-aromatic spirocyclic carbon bicyclic or carbon tricyclic system;

[0012] R 3 It is a C1-C3 alkyl, a C1-C3 haloalkyl, or a C3-C6 cycloalkyl or C1-C2 alkyl;

[0013] or its salts or N-oxides; and

[0014] Component (B) is a compound selected from the group consisting of:

[0015] Azoxystrobin, oxadiazon, azoxystrobin, pyraclostrobin, eugenol, metyltetraprole, cycloconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, cyclophosphamide, prothioconazole, chlorfluazuron, prochloraz, benzalkonium chloride, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzovindiflupyr, fluopyram, isoflucypram, bifenpyraclostrobin, pyrapropoyne, inpyrfluxam, pyrapropoyne, fluopyram, fenpicoxa (mid), florylpicoxamid, aramid-type benzene-S-methyl, anti-rot ester, aluminum triethylphosphonate, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, isobutylethoxyquinoline, topvail, tricyclazole, fluazinam, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be derived from WO (Prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be prepared by the method described in WO 2016 / 202688); N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be prepared by the method described in WO 2016 / 202688); N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (these compounds can be prepared by the method described in WO 2016 / 202688); N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl- Prepared by the method described in 2017 / 153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, (these compounds can be prepared by WO Prepared by the method described in WO 2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, (these compounds can be prepared by the method described in WO 2016 / 156085);N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium (these compounds can be prepared by the method described in WO 2015 / 155075); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium (this compound can be prepared by WO 2015 / 155075) Prepared by the method described in 2018 / 228896); N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (these compounds can be derived from WO4) Prepared by the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689;(Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (these compounds can be derived from WO Prepared by the method described in 2020 / 079111); methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, ( Methyl (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methylphenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazolyl)-2-methylphenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoate, (i.e., Bacillus amyloliquefaciens strain FZB24), Timorex Gold TM (Plant extracts containing tea tree oil), and metarylpicoxamid.

[0016] Typically, the weight ratio of component (A) to component (B) can preferably be from 100:1 to 1:100, from 50:1 to 1:50, from 20:1 to 1:40, from 15:1 to 1:30, from 12:1 to 1:25, from 10:1 to 1:20, from 5:1 and 1:15, from 3:1 to 1:10, or from 2:1 to 1:5.

[0017] In addition, according to the present invention, a method for controlling or preventing plant pathogenic diseases, especially plant pathogenic fungi, on useful plants or their propagation material is provided, the method comprising applying a fungicidal composition according to the present invention to such useful plants, their sites or their propagation material.

[0018] The benefits provided by certain fungicidal mixture compositions according to the invention may also include, in particular, favorable levels of bioactivity for protecting plants against fungal diseases or superior properties for use as active ingredients in agrochemicals (e.g., greater bioactivity, favorable activity spectrum, increased safety, improved physicochemical properties, or increased biodegradability).

[0019] The presence of one or more possible asymmetric carbon atoms in a compound having formula (I) means that the compound can exist in optical isomers (i.e., enantiomers or diastereomers). As a result of restricted rotation around the single bond, transisomers may also exist. Formula (I) is intended to include all those possible isomer forms and mixtures thereof. This invention includes all those possible isomer forms and mixtures thereof of compounds having formula (I). Similarly, formula (I) is intended to include all possible tautomers. This invention includes all possible tautomer forms of compounds having formula (I). In each case, the compound having formula (I) according to the invention is in a free form, an oxidized form such as an N-oxide, or a salt form (e.g., an agronomically usable salt). The N-oxide is an oxidized form of a tertiary amine or an oxidized form of a nitrogen-containing heteroaromatic compound. For example, A. Albini and S. Pietra described them in their book "Heterocyclic N-oxides" published in 1991 by CRC Press in Boca Raton.

[0020] The preferred groups and values ​​of substituents in compounds having formula (I), in any combination thereof, are listed below:

[0021] Y is either CF or CH. In one set of embodiments, Y is CF. In another set of embodiments, Y is CH.

[0022] X is N.

[0023] R 1 It is a C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, or HC(O)NH-. Preferably, R 1 It is a C1-C3 alkyl group or HC(O)NH-. More preferably, R 1 It is a methyl group.

[0024] R 2 It is a C1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl, C1-C2 alkyl (wherein the cycloalkyl is optionally composed of 1 to 3 R 3 (represented by a substituent group), phenyl, phenyl C1-C2 alkyl (wherein the phenyl ring is optionally replaced by 1 to 3 R groups). 3The indicated group substitution), or a 5- to 12-membered non-aromatic spirocyclic carbon bicyclic or carbon tricyclic system. Preferably, R 2 It is a C1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl, C1-C2 alkyl (wherein the cycloalkyl group is optionally composed of one or two R groups). 3 (represented by a substituent group), phenyl, phenyl C1-C2 alkyl (wherein the phenyl ring is optionally replaced by one or two R groups). 3 The indicated group substitution), or a 5- to 12-membered non-aromatic spirocyclic carbon bicyclic or carbon tricyclic system. More preferably, R 2 It is n-butyl, isobutyl, n-pentyl, isopentyl, 2,2-dimethylpropyl, n-hexyl, 1-(cyclopropylmethyl)cyclopropylmethyl, cyclobutyl, 2,2-dimethylcyclobutyl, 1-methylcyclopentyl, benzyl, 1-phenylethyl, 3,5-bis(trifluoromethyl)benzyl, spiro[3.3]heptyl, spiro[3.4]octyl or spiro[cyclobutane-1,2'-indane], and most preferably 1-(cyclopropylmethyl)cyclopropylmethyl, cyclobutyl, 2,2-dimethylcyclobutyl, spiro[3.3]heptane-3-yl, spiro[3.4]octane-3-yl or spiro[cyclobutane-1,2'-indane]-1-yl.

[0025] R 3 It is a C1-C3 alkyl, C1-C3 haloalkyl, or C3-C6 cycloalkyl / C1-C2 alkyl. Preferably, R 3 It is methyl, trifluoromethyl, or cyclopropylmethyl.

[0026] Preferably, component (A) is a compound selected from the following:

[0027] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.01);

[0028] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.02);

[0029] 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.03);

[0030] 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.04);

[0031] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.05);

[0032] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-carbamoyl-thiazolyl-4-carbamoyl (compound X.06);

[0033] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.07);

[0034] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[cyclobutane-2,2'-inden]-1-yl-thiazolyl-4-carboxamide (compound X.08);

[0035] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide (compound X.09);

[0036] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-[[1-(cyclopropylmethyl)cyclopropyl]methyl]-5-methyl-thiazolyl-4-carboxamide (compound X.10);

[0037] 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.11);

[0038] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.12);

[0039] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide (compound X.13);

[0040] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide (compound X.14);

[0041] 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.15);

[0042] 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-phenylethyl)thiazole-4-carboxamide (compound X.16);

[0043] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazolyl-4-carboxamide (compound X.17);

[0044] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazolyl-4-carboxamide (compound X.18);

[0045] 2-[cyano-(5-fluoro-3-pyridyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide (compound X.19);

[0046] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide (compound X.20);

[0047] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-isopentyl-5-methyl-thiazolyl-4-carboxamide (compound X.21);

[0048] N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.22);

[0049] N-Benzyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide (compound X.23); and N-Butyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide (compound X.24).

[0050] More preferably, component (A) is a compound selected from the following:

[0051] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.01);

[0052] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.02);

[0053] 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.03);

[0054] 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.04);

[0055] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.05);

[0056] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.07);

[0057] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide (compound X.09);

[0058] 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.11);

[0059] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.12);

[0060] X.14, X.15, X.16, X.17, X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide (compound X.14);

[0061] 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.15);

[0062] 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-phenylethyl)thiazole-4-carboxamide (compound X.16);

[0063] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazolyl-4-carboxamide (compound X.17);

[0064] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazolyl-4-carboxamide (compound X.18); and

[0065] N-Butyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.24).

[0066] Even more preferably, component (A) is selected from compounds including:

[0067] 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.01);

[0068] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.02);

[0069] 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.03);

[0070] 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.04);

[0071] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.05);

[0072] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.07);

[0073] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide (compound X.09);

[0074] 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.11);

[0075] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide (compound X.12);

[0076] X.14, X.15, X.16, X.17, X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide (compound X.14); and

[0077] 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazolyl-4-carboxamide (compound X.18).

[0078] Table X

[0079]

[0080]

[0081]

[0082]

[0083]

[0084]

[0085] Preferably, component (B) is a compound selected from the group consisting of:

[0086] Azoxystrobin, oxadiazon, azoxystrobin, pyraclostrobin, eugenol, metyltetraprole, cycloconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, cyclophosphamide, prothioconazole, chlorfluazuron, prochloraz, benzyl methoxyfenozide, benzoyl methoxyfenozide, fluopyram, fluopyram, pyrapropoyne, fluopyram, benzoyl methoxyfenozide, fluopyram, isoflucypram, bifenthiophanate-methyl, pyrapropoyne, fluopyram, florylpicoxamid, aramacin-S-methyl, anti-rot ester, aluminum tris(ethyl phosphonate), chlorothalonil, mancozeb, diyrylamide Amines, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, isobutylethoxyquinoline, topvail, tricyclazole, cycloflufenoxam, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline -3-Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl) )-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidin, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidin, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidin, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethyl oxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy] Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl)phenoxy]methyl propionate, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate Methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazo-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazo-2-yl]phenoxy]prop-2-enoate, (i.e., Bacillus amyloliquefaciens strain FZB24), Timorex Gold TM(Plant extracts containing tea tree oil), and metarylpicoxamid.

[0087] More preferably, component (B) is a compound selected from the group consisting of:

[0088] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyraclostrobin, fluoxastrobin, benzyl hydroxylamine, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofume lin, tricyclazole, quinolones, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5 -Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl) [5-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-] (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl] Methyl propionate (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methylphenoxy]-3-methoxy-propionate (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propionate (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propionate (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxy-propionate (Z)-2-(5-cyclopentyl-2-methylphenoxy) Methyl 3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methylphenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methylphenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-bromothiazolyl)-2-methylphenoxy]-3-methoxy-propane-2-enoate, and (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]propane-2-enoate.

[0089] More preferably, component (B) is a compound selected from the group consisting of:

[0090] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron, fluoxastrobin, benzyl-methyl, fluoxastrobin, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrapropoyne, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber. N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

[0091] In one set of embodiments, component (B) is a compound selected from the group consisting of:

[0092] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron, fluoxastrobin, benzyl-methyl, fluoxastrobin, benzovindiflupyrrolidone, bifenthiophanate-methyl, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, metarylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, alaropyram Acidic benzene-S-methyl, cycloflufenicol, benomyl, fluazinam, aluminum triethylphosphonate, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro -3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, and Timorex Gold TM .

[0093] In a particularly preferred set of embodiments, component (B) is a compound selected from the group consisting of:

[0094] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron, fluoxastrobin, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fluazinam, fludioxonil, pyrapropoyne, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline Phosphorus, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop- 2-Ocenoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and ethyl pyrazole-4-carboxylate.

[0095] These component (B) compounds are referred to herein and above by their so-called "ISO common name" or another "common name" or trademark name, as used in individual cases. These component (B) compounds are known and commercially available and / or can be prepared using procedures known in the art and / or procedures reported in the literature.

[0096] In the preferred composition according to the invention, component (A) is compound number X.01, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzoyl benzoate, benzoyl benzoate Azoxystrobin, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquin, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4, 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0097] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, pyraclostrobin, fluopyram, Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0098] In another preferred composition according to the invention, component (A) is compound number X.03, 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluazinam, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy] [N-(2-methyl-phenyl)-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0099] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0100] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0101] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-carbamoyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0102] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0103] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[cyclobutane-2,2'-indan]-1-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyridaben Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0104] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0105] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-[[1-(cyclopropylmethyl)cyclopropyl]methyl]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, etc. Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0106] In another preferred composition according to the invention, component (A) is compound number X.11, 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, and fluopyram. Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymecium benzoate, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0107] In another preferred composition according to the invention, component (A) is compound number X.12, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0108] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzo[a]ene Fluopyram, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5- [Methyl-phenyl]-N-ethyl-N-methylformamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0109] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0110] In another preferred composition according to the invention, component (A) is compound number X.15, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin ... Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0111] In another preferred composition according to the invention, component (A) is compound number X.16, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-phenylethyl)thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Azoxystrobin, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [N-(2-methyl-phenyl)-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0112] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0113] In another preferred composition according to the invention, component (A) is compound number X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0114] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzo[a]ene Fluopyram, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5- [Methyl-phenyl]-N-ethyl-N-methylformamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0115] In another preferred composition according to the invention, component (A) is compound number X.20, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0116] In another preferred composition according to the invention, component (A) is compound number X.21, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-isopentyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0117] In another preferred composition according to the invention, component (A) is compound number X.22, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0118] In another preferred composition according to the invention, component (A) is compound number X.23, N-benzyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0119] In another preferred composition according to the invention, component (A) is compound number X.24, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyloxydine, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0120] In a more preferred composition according to the invention, component (A) is compound number X.01, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, etc. Chlorpyrimethanil, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyr Ifen, Sterilizer, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl The compounds are 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0121] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Thiophanate, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, amino Pyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0122] In another preferred composition according to the invention, component (A) is compound number X.03, 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorfenapyr, benzyl benzoate, buprofen, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3- Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0123] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Cycloazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzyl-methyl, fluoxastrobin, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, am Inopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0124] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0125] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-carbamate-thiazol-4-carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, difenoconazole, and hexazinazole. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0126] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0127] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[cyclobutane-2,2'-inden]-1-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, and difenoconazole. Azoxystrobin, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl- M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0128] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0129] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-[[1-(cyclopropylmethyl)cyclopropyl]methyl]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, and difenoconazole. Azoxystrobin, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl- M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0130] In another preferred composition according to the invention, component (A) is compound number X.11, 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Thiophanate, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, amino Pyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0131] In another preferred composition according to the invention, component (A) is compound number X.12, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorfenapyr, benzyl benzoate, buprofen, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3- Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0132] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, and prothioconazole. , chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, pyraclostrobin, fluoxastrobin, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyridaben Rifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl The compounds are 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0133] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0134] In another preferred composition according to the invention, component (A) is compound number X.15, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Thiophanate, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, amino Pyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0135] In another preferred composition according to the invention, component (A) is compound number X.16, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-phenylethyl)thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorfenapyr, benzyl benzoate, buprofen, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3- Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0136] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorfenapyr, benzyl benzoate, buprofen, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3- Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0137] In another preferred composition according to the invention, component (A) is compound number X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0138] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, and prothioconazole. , chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, pyraclostrobin, fluoxastrobin, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyridaben Rifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl The compounds are 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0139] In another preferred composition according to the invention, component (A) is compound number X.20, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0140] In another preferred composition according to the invention, component (A) is compound number X.21, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-isopentyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0141] In another preferred composition according to the invention, component (A) is compound number X.22, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0142] In another preferred composition according to the invention, component (A) is compound number X.23, N-benzyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0143] In another preferred composition according to the invention, component (A) is compound number X.24, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0144] In the preferred composition according to the invention, component (A) is compound number X.01, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzoyl benzoate, benzoyl benzoate Azoxystrobin, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquin, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4, 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0145] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, pyraclostrobin, fluopyram, Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0146] In another preferred composition according to the invention, component (A) is compound number X.03, 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0147] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0148] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0149] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-carbamoyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0150] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0151] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[cyclobutane-2,2'-indan]-1-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyridaben Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0152] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0153] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-[[1-(cyclopropylmethyl)cyclopropyl]methyl]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, etc. Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0154] In another preferred composition according to the invention, component (A) is compound number X.11, 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, and fluopyram. Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymecium benzoate, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0155] In another preferred composition according to the invention, component (A) is compound number X.12, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0156] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzo[a]ene Fluopyram, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5- [Methyl-phenyl]-N-ethyl-N-methylformamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0157] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0158] In another preferred composition according to the invention, component (A) is compound number X.15, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin ... Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0159] In another preferred composition according to the invention, component (A) is compound number X.16, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-phenylethyl)thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Azoxystrobin, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [N-(2-methyl-phenyl)-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0160] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Cyclopyr, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluinazole, Benzopyrimidazole, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Dipyridamole, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclopyr, Benzophenone, N'-[2-chloro-4-(2-fluorophenoxy)] [4-(2-bromophenoxy)-5-chloro-2-methylphenyl]-N-ethyl-N-methylformamidin, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0161] In another preferred composition according to the invention, component (A) is compound number X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0162] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzo[a]ene Fluopyram, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5- [Methyl-phenyl]-N-ethyl-N-methylformamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methylformamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0163] In another preferred composition according to the invention, component (A) is compound number X.20, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0164] In another preferred composition according to the invention, component (A) is compound number X.21, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-isopentyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzo[a]pyrethroid ... Enfluopyram, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cyclofluopyram, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5 [-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4 5-Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0165] In another preferred composition according to the invention, component (A) is compound number X.22, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0166] In another preferred composition according to the invention, component (A) is compound number X.23, N-benzyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, etc. Andonazole, fluopyram, isoflucypram, pyrapropoyne, fluinazole, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)- [5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0167] In another preferred composition according to the invention, component (A) is compound number X.24, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyloxydine, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0168] In the preferred composition according to the invention, component (A) is compound number X.01, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, etc. Benzoic acid, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, i pflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethylisoquinoline, 4,4-difluoro-3 3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0169] In another preferred composition according to the invention, component (A) is compound number X.02, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, etc. Fluopyram, benzyl sulfadiazine, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl sulfadiazine, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, and other fungicides. Mancozeb, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro -3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0170] In another preferred composition according to the invention, component (A) is compound number X.03, 2-(N-cyano-3,5-difluoro-aniline)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen Sterilizer, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-di Fluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0171] In another preferred composition according to the invention, component (A) is compound number X.04, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Thiophanate, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrife n, piflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-di Fluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0172] In another preferred composition according to the invention, component (A) is compound number X.05, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0173] In another preferred composition according to the invention, component (A) is compound number X.06, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-carbamate-thiazol-4-carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Azoxystrobin, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrimethanil fen, sterilizing cap, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0174] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0175] In another preferred composition according to the invention, component (A) is compound number X.08, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[cyclobutane-2,2'-inden]-1-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyridaben Rifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4 -Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0176] In another preferred composition according to the invention, component (A) is compound number X.09, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.3]heptane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0177] In another preferred composition according to the invention, component (A) is compound number X.10, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-[[1-(cyclopropylmethyl)cyclopropyl]methyl]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyridaben Rifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4 -Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0178] In another preferred composition according to the invention, component (A) is compound number X.11, 2-(N-cyano-3,5-difluoro-aniline)-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, etc. Chlorpyrimethanil, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, and other fungicides. Mancozeb, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro -3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0179] In another preferred composition according to the invention, component (A) is compound number X.12, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-methylcyclopentyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen Sterilizer, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-di Fluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0180] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazuron. Azoxystrobin, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0181] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorofluorocarbons Azoxystrobin, benzyl sulfadiazine, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl sulfadiazine, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, sterilization Dan, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0182] In another preferred composition according to the invention, component (A) is compound number X.15, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-isobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, etc. Fluopyram, benzyl sulfadiazine, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl sulfadiazine, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, and other fungicides. Mancozeb, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro -3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0183] In another preferred composition according to the invention, component (A) is compound number X.16, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-(1-phenylethyl)thiazole-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, and prothioconazole. Azoxystrobin, chlorfluazuron, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen Sterilizer, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-di Fluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0184] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl Azoxystrobin, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen Sterilizer, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-di Fluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0185] In another preferred composition according to the invention, component (A) is compound number X.18, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0186] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[cyano-(5-fluoro-3-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazuron. Azoxystrobin, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0187] In another preferred composition according to the invention, component (A) is compound number X.20, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-pentyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos. Azoxystrobin, benzyl sulfadiazine, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl sulfadiazine, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, sterilization Dan, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0188] In another preferred composition according to the invention, component (A) is compound number X.21, 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-isopentyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorofluorocarbons. Azoxystrobin, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0189] In another preferred composition according to the invention, component (A) is compound number X.22, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0190] In another preferred composition according to the invention, component (A) is compound number X.23, N-benzyl-2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos. Azoxystrobin, benzyl sulfadiazine, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl sulfadiazine, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridaben, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, sterilization Dan, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro- 3,3-Dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0191] In another preferred composition according to the invention, component (A) is compound number X.24, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0192] In the preferred composition according to the invention, component (A) is compound number X.05, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyloxydine, butylbenzyl... Morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzylfluopyram, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumeli n, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-di... 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa] [Diazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably, from 5:1 to 1:5.

[0193] In another preferred composition according to the invention, component (A) is compound number X.07, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazuron, benzyl sulfadiazine , Butyram, Fluopyram, Fluopyram, Pyrazosulfuron, Fluopyram, Benzoylfluopyram, Fluopyram, Isoflucypram, Pyrapropoyne, Fluopyram, Benzopyram, Florylpicoxamid, Chlorothalonil, Mancozeb, Dimethomorph, Thiabenazol, Fluazinam, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofume lin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5- Dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa] [Diazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably, from 5:1 to 1:5.

[0194] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluazole Azoxystrobin, fluopyram, pyrapropoyne, fluoxastrobin, benzimidazole, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzimidazole, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, triadimefon Cycloazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethyl-3,3-dimethyl-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethyl-3,3-dimethyl-3,3-dimethyl-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethyl-3,3 ... 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benom...

Claims

1. A fungicidal composition comprising a mixture of components (A) and (B) as an active ingredient, wherein component (A) is a compound selected from 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.05); 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazol-4-carboxamide (compound X.07); 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-hexyl-5-methyl-thiazol-4-carboxamide (compound X.14); and Component (B) is a compound selected from the group consisting of: Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron-methyl, fluopyram, benzyl-methyl, fluopyram, chlorothalonil, mancozeb, dimethomorph, thiamethoxam Fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro -3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxy-prop-2-enoate methyl ester, (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxy-prop-2-enoate methyl ester, bifenthiophanate, or aluminum triethylphosphonate; and The weight ratio of component (A) to component (B) ranges from 20:1 to 1:

40.

2. The antifungal composition according to claim 1, wherein, Component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron-methyl, fluopyram, benzyl-methyl, fluopyram, pyrapropoyne, fluopyram, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, fludioxonil, azoxystrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoq uin, quinofumelin, tricyclazole, cycloquinone, cycloflufenazate, benomyl, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate methyl ester, bifenthiophanate, or aluminum triethylphosphonate.

3. The antifungal composition according to claim 1 or claim 2, wherein, Component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron, fluopyram, benzyl-methyl, fluopyram, isoflucypram, isopropyram, pyrapropoyne, fluopyram, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fluazinam, fludioxonil, azoxystrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, and N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide.

4. The antifungal composition according to claim 1 or claim 2, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05).

5. The antifungal composition according to claim 1 or claim 2, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.4]octane-3-yl-thiazolyl-4-carboxamide (compound X.07).

6. The antifungal composition according to claim 1 or claim 2, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-hexyl-5-methyl-thiazolyl-4-carboxamide (compound X.14).

7. The antifungal composition according to claim 1 or claim 2, wherein the composition is for controlling Zymoseptoria tritici, Botrytis cinerea, Colletotrichum lagenarium, Cercospora arachidicola, Pyricularia oryzae, Monographaella nivalis, Cercospora beticola, Pyrenophora teres, Alternaria solani, Sclerotinia sclerotiorum, Blumeria graminis, Puccinia recondita, or Phakopsora pachyrhizi.

8. The antifungal composition according to claim 1 or claim 2, wherein, The weight ratio of component (A) to component (B) ranges from 12:1 to 1:

25.

9. The antifungal composition according to claim 1 or claim 2, wherein, The weight ratio of component (A) to component (B) is from 5:1 and 1:

15.

10. The antifungal composition according to claim 1 or claim 2, wherein, The weight ratio of component (A) to component (B) ranges from 2:1 to 1:

5.

11. The antifungal composition according to claim 1 or claim 2, wherein, The composition comprises one or more additional pest control agents selected from the group consisting of: The fungicide, wherein the fungicide is selected from tebuconazole, fluazinam, benzovindiflubenzuron, fluopyram, benzalkonium chloride, benzalkonium chloride-M (refined benzalkonium chloride), furazolidone, metalaxyl, metalaxyl-M (refined metalaxyl), doxycycline, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidinium, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl] [N-Ethyl-N-Methyl-Formamidin, Ethioprine, 3'-Chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]acetyl-2',6'-dimethylaniline (Imidacloprid), Azoxystrobin, Azoxystrobin, Pyrimethanil, Dithionon, Nystatin Aureobasidium, Pyroxyphenidyl-S, Biphenyl, Dimethomorph, Chlornitramine, Hexachlorobenzene, Pentachloronitrobenzene, Tetraoxonylnitrobenzene (TCNB), Methylthiophos, Benzophenone, 2,6-Dichloro-N-(4-trifluoromethylbenzyl)-Benzamide, Fluopyram, Thiocyanamide, Sulfocarbamide, Benomyl, Carbendazim, Carbendazim Hydrochloride, Chlorfenapyr, Wheat-Spinazole Thiabendazole, thiophanate-methyl, bensulfuron-methyl, mefenoxam, thiabendazole, aramacin, benzoyl permethrin, pyraclostrobin (IKF-309), aramacin-phenyl-S-methyl, pyraclostrobin (KIF-7767), butylamine, 3-iodo-2-propynyl n-butylcarbamate (IPBC), piperazine, polycarbamate, cymoxanil, trifluoromethoxycarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, dichloroisocyanurate, N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(dichloro-2-isopropyl-phenyl)methyl Fluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methylpyrazole-4-carboxamide, cyprothiophanate-methyl, chlorothalonil, flumorph, quinoline copper, cymoxanil, cyazofamid, cymoxanil, fluoxastrobin, thiamethoxam, ethoxysulfuron, iprodione, procymidone, fenvalerate, sulfadiazine, chlorpyrifos, chlorfenapyr, chlorfenapyr, chlorfenapyr, diphenylamine, chlorfenapyr, 2,6-dimethyl-[1,4]dithiazoline[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-Tetraketone, Frucium oxychloride, Mancozeb, Ferrous thiophanate-methyl, Mancozeb, Mancozeb, Mancozeb, Mancozeb-zinc, Sodium mancozeb, Methyl mancozeb, Frucium oxychloride, Verbam (Sodium Mancozeb), Zinc mancozeb, Zinc thiram, Dimethyl disulfide, Isoprothiolane, Thiazolamide, Tris(ethyl phosphonic acid), Aluminum tris(ethyl phosphonic acid), Iodomethyl, Methyl isothiocyanate, Cyclomethrin, Mefenoxam, Validamycin, Streptomycin, (2RS)-2-bromo-2-(bromomethyl)glutaronitrile (Bromoxynil), Polyfop-methyl, Dodecyl guanidine acetate, Biguanidine octyl salt, Biguanidine octylamine, Biguanidine octylamine triacetate, 2,4-D, 2,4-DB, Kasugamycin, Mefenoxam, Cyclomethrin, Hymexazol, Sodium thiophanate, Imazol, Imazol sulfate, Oxadiazol, Isoprothiolane Imazalil, Fluopyram, Imidacloprid, Bordeaux mixture, Calcium polysulfide, Copper acetate, Copper carbonate, Copper hydroxide, Copper naphthenate, Copper oleate, Copper oxychloride, Copper hydroxyquinoline, Copper silicate, Copper sulfate, Copper fatty acid, Cuprous oxide, Sulfur, Carbaryl, Tetrachlorophthalide, Azoxystrobin, Thiapaveril, Furazolidone, Dimethomorph, KSF-1002, Benzomorph, Dimethomorph, Butylmorpholine, Tridemorpholine, Dodecylmorpholine, Ethiocarb, Triphenyltin acetate, Triphenyltin hydroxide, Carbendazim, Oxytetracycline, Dimethomorph, Oxytetracycline, Oxytetracycline, Oxytetracycline, m-Phenylephrine, p-Phenylephrine, Tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolinyl)oxy]-6-fluoro-phenyl]propane Alkyl-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]phenyl]propane-2-ol, Cycloflubenzuron, Furazolidone, Oxychlorophenoxyacetate, Fluopyram, Cymoxanil, Isopropylthiophanate-methyl, Seed dressing, Fludioxonil, Pendimethalin, Carbendazim, Isopyram, Phosphate, Phosphate, Leaf blight phthalate, Captan, Captan, Phosphate, Azoxystrobin, Benzoyl sulfadiazine, Phenylephrine, Osthol, 1-Methylcyclopropene, 4-CPA, Chlormequat chloride, Benaziridine, 2,4-D propionic acid, Thiamethoxam, Indomethacin, Ethephon, Fludioxonil, Chlorpyrifos, Gibberellin, Glycyrrhizin, Hymexazol, Maleic hydrazine, Tocopherol, Naphthylacetamide, Paclobutrazol, Cyclobutrazol, Calcium Cyclobutrazol, Thiidanone, Defoliant (Tributyl Trithiophosphate), Anti-rot ester, Uniconazole, α- Naphthaleneacetic acid, polyoxin D (polyoxin-Remo), BLAD, chitosan, cyanamide, captan, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bifenthiophanate, fluopyram, furazolidone, pyrazolenaphthalene, pendimethalin, pyrimethanil, fluoxastrobin, pyridaben, pyridaben, pyridaben, pyridaben, fluopyram, diflubenzuron, chlorophenazinol, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, pyrimethanil, sclerotinib, quinolones, propoxyquin, ethoxyquin, quinoxaline, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolinyl)isoquinoline, 4,4-difluoro-3,3-Dimethyl-1-(3-quinolinyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolinyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolinyl)-3H-1,4-benzoxazine, isobutylethoxyquinoline, oxaflutole, pyrimethanil, (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide, azoxystrobin, eugenol, fenazate, pyriotrobin, fenazate, fluopyram, fluopyram, fenazate, mandesbin, benoxystrobin, benoxystrobin, oxadiazate, pyrimethanil, azoxystrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, chlorpyrifos, oxime Azoxystrobin, indazole, thiamethoxam, parathion, butyl-3-ynyl N-[6-[[(Z)-[(1-methyltetrazole-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, dazomet, isothiazamide, thiamethoxam, thifluzamide, benzothiamethoxam (TCMTB), thiosilazamide, benzylazamide, tricyclazole, (.+-.)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (cyclohexazole), 1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propane-2-ol, 2-(1-tert-butyl)-1-( 2-Chlorophenyl)-3-(1,2,4-triazol-1-yl)-propane-2-ol (TCDP), (N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium), azaconazole, bifenthrin (bifenthrin), furazolidone, clomidazole, cyclophosphamide, difenoconazole, tebuconazole, tebuconazole-M, flutriafol, eticonazole, cyproconazole, fluquinazole, flusilazole, fenbendazole, hexaconazole, imidacloprid, tebuconazole, propiconazole, thiophanate-methyl, chlorfluazol, silfluazol, tebuconazole, tetraflufenazole, triadimefon, triadimefon, imidazolimide, tebuconazole, 2-[[(1R,5 S)-5-[(4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazol-3-thione, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)ethyleneoxy-2-yl]methyl]-4H-1,2,4-triazol-3-thione, imidium, isopropylamine, cymoxanil, 2-benzyl-4-chlorophenol (benzylchlorophenol), allyl alcohol, pyrazosulfuron, benzalkonium chloride, chloropicrin, cresol, daracide, diclofenac, oat meal, disulfiram, N-(2-p-chlorobenzoylethyl)-lead hexachloride, NNF-0721, octathione, pyrimisulfuron, Timorex Gold, TM (Plant extracts containing tea tree oil), propanemidine, and propionic acid; or Insecticides, wherein the insecticides are selected from abamectin, chlorpyrifos, acetamiprid, sulfadiazine (S-1955), abamectin, azadirachtin, methyl phosmet, bifenthrin, bifenazate, rice lice control agent, carbofuran, batan, chlorantraniliprole (DPX-E2Y45), brofenoxam, flufenoxam, methyl chlorpyrifos, cyclophosphamide, thiamethoxam, diflubenzuron, β-cyhalothrin, deltamethrin, lambda-cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, difenoconazole, diazinon, dieldrin, diflubenzuron, tetrafluoroethylene, dimethoate, dinotefuran, benzyl ether, emamectin, cypermethrin, acetamiprid, fenthion, fenoxycarb, cypermethrin, fenvalerate, fipronil, etc. Flupyradifonamide, flufenoxuron, cypermethrin, t-flufenoxuron, pyrimethanil (UR-50701), flufenoxuron, terbufos, chlorfenapyr, flufenoxuron, flufenoxuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, cyfluthrin, metaldehyde, methomyl, acetamiprid, methoxychloride, methoxyfenozide, acetamiprid, nifediazole, diphenylfluorourea, polyfluorourea (XDE-007), nematicide, permethrin, pirimicarb, profenofos, propargite, pymetrozine, pyrethroids, acetamiprid, flufenoxuron, pyrethroids, acetamiprid, flufenoxuron, pyraclostrobin, pyrethroids, rotenone, linanodin, spinosad, spinosad, spirodiclofen, spirodiclofen (BSN) 2060), spirotetramat, thiophanate-methyl, tebufenozide, flufenoxuron, heptafluthrin, thiamethoxam, thiamethoxam, carbaryl, tetramethrin, pymetrozine, trichlorfon, and chlorpyrifos; or Bactericide, wherein the bactericide is selected from streptomycin; or Acaricides, wherein the acaricides are selected from amitraz, chlorfenapyr, chlorpyrifos, pyridaben, tricyclic tin, chlorfenapyr, etoxazole, quinclorac, fenbutatin, cypermethrin, bamectin, thiamethoxam, dicofol, pyridaben, and pyridaben; or Biological reagents, wherein the biological reagents are selected from Bacillus thuringiensis, Bacillus thuringiensis δ-endotoxin, baculoviruses, insect pathogenic bacteria, viruses, and fungi.

12. A method for controlling or preventing plant pathogenic fungi on a useful plant, the method comprising applying a fungicidal composition as defined in any one of claims 1 to 11 to the useful plant or its location.

13. A method for controlling or preventing plant pathogenic fungi on the propagation material of a useful plant, the method comprising applying a fungicidal composition as defined in any one of claims 1 to 11 to the propagation material of the useful plant.

Images